# Antares Therapeutics

**Canonical:** https://apis.io/providers/antares-therapeutics/  
**Website:** https://antaresrx.com  
**APIs profiled:** 1

Antares Therapeutics is a Boston- and South San Francisco-based precision medicine company developing small-molecule therapies against validated but previously undruggable targets in cancer and other serious diseases. Spun out of Scorpion Therapeutics following Eli Lilly's March 2025 acquisition of Scorpion, Antares launched in June 2025 with a $177 million Series A co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners and Cormorant Asset Management. The company combines medicinal chemistry (proprietary compound libraries and next-generation mass spectrometry to find new chemical pockets), target biology (first-in-class preclinically validated targets and allosteric approaches to clinically validated ones), and predictive sciences (physics-based modeling, machine learning and molecular dynamics) to shorten discovery cycles. Its most advanced program is expected to enter the clinic in 2026, with multiple additional preclinical programs and discovery collaborations with Novartis, AstraZeneca and Pierre Fabre Laboratories. Antares is a private, preclinical-stage biotechnology company and publishes no public product API, developer portal or SDK surface.

## Kin Score — 16.7 / 100 (emerging)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 16.7).

| Facet | Score |
|---|---|
| Discoverability | 75.9 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 14.3 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 32.5 (matched via tags).

## Agent readiness — 12.6 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | yes |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Open access — onboarding: open, pricing: unknown, trial: no (confidence: medium).

## APIs (1)

- **Antares Therapeutics WordPress REST API** — The public WordPress REST API behind antaresrx.com. This is the content management surface for the corporate marketing site and its press-release / in-the-media newsroom -- it i...

## MCP servers (1)

- **Antares Therapeutics MCP Server**

## Security (3)

- **Antares Therapeutics Authentication** — 0 schemes
- **Antares Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC
- **Antares Therapeutics Vulnerability Disclosure** — Hackerone · security.txt · contact published

## Tags

Company, Biotechnology, Pharmaceuticals, Precision Medicine, Oncology, Drug Discovery, Life Sciences, Machine-Learning

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/antares-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.